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Abstract:  Retroviral gene expression generally depends on a full-length transcript that 
initiates in the 5' long terminal repeat (LTR), which is either unspliced or alternatively 
spliced. We and others have demonstrated the existence of an antisense transcript initiating 
in the 3' LTR of the Human T-cell Leukemia Virus type 1 (HTLV-1) that is involved in the 
production of HBZ (HTLV-1 basic leucine zipper (bZIP) factor). HBZ is a Fos-like factor 
capable of inhibiting Tax-mediated activation of the HTLV-1 LTR by interacting with the 
cellular  transcription  factor  cAMP-response  element-binding  protein  (CREB)  and  the 
pleiotropic cellular coactivators p300/CBP. HBZ can also activate cellular transcription 
through its interaction with p300/CBP. Interestingly, HBZ has also been found to promote 
T-lymphocyte proliferation. By down-regulating viral expression and by stimulating T-cell 
proliferation, HBZ could be essential in the establishment of a chronic infection. Antisense 
transcription also occurs in the closely related HTLV-2 retrovirus as well as in the recently 
discovered  HTLV-3  and  HTLV-4.  These  antisense  transcripts  are  also  involved  in  the 
production of retroviral proteins that we have termed Antisense Protein of HTLVs (APH). 
Like HBZ, the APH proteins are localized in the nucleus of transfected cells and repress 
Tax-mediated viral transcription.  
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1. Introduction  
Human T-cell leukemia virus type 1 (HTLV-1) is a complex lymphotropic retrovirus classified in 
the Deltaretrovirus genus of the retrovirus family. Other members include HTLV-2, -3, and -4, the 
simian T-cell lymphotropic viruses (STLV-1, -2, and -3) and the bovine leukemia virus. HTLV-1 is 
associated with adult T-cell leukemia (ATL) and a slowly progressive neurologic disorder, HTLV-1 
associated  myelopathy/tropical  spastic  paraparesis  (HAM/TSP).  ATL  develops  after  a  prolonged 
latency period of up to 30–50 years postinfection and is an aggressive lymphoproliferative disease 
with different clinical stages considered to gradually progress from carrier to smoldering, chronic, and 
acute-type leukemia [1]. Leukemic cells in ATL are almost exclusive CD4
+ T cells. HAM/TSP has a 
shorter incubation period than ATL and can show an accelerated development within one month to 
four years after transfusion of the infected blood sample. The main pathologic features of HAM/TSP 
are chronic inflammation in the spinal cord, characterized by perivascular lymphocytic cuffing and 
parenchymal  lymphotropic  infiltration  including  HTLV-1-infected  CD4
+  T  cells  [2].  Unlike  human 
immunodeficiency  virus  type  1,  HTLV-1  causes  no  disease  in  a  majority  of  infected  subjects. 
Approximately 2% to 3% develop ATL and another 2% to 3% develop a disabling chronic inflammatory 
disease involving the central nervous system (HAM/TSP), eyes, lungs, or skeletal muscles. 
As with most retroviruses, HTLV-1 begins its cycle with the infection of target cells. Following 
viral entry, the viral RNA genome is reverse transcribed into a double-stranded DNA molecule and 
enters the nucleus as a nucleic acid-protein complex, which mediates the integration of proviral DNA 
into the host chromatin. The proviral DNA possesses two long terminal repeats, the 5' and 3' LTRs, 
composed of three regions, U3, R, and U5. The U3 region of the LTR contains important elements like 
the Tax-responsive elements (TxREs). The viral Tax protein does not bind specifically to the TxREs 
but  interacts  with  some  members  of  the  activating  transcription  factor/CRE-binding  (ATF/CREB) 
proteins such as CREB and CREB-2 [3,4] that are able to bind to TxRE DNA regions (Figure 1). The 
formation of such a complex on the 5' LTR then serves as a binding site for the recruitment of the 
pleiotropic cellular coactivators p300/CBP through its interaction with Tax. Recruitment of p300/CBP 
to the viral promoter induces local nuclesosome modification by histone acetylation and facilitates 
stable binding of components of the basal transcription machinery allowing the stimulation of viral 
transcription [5] and ensuing synthesis of the viral proteins including Gag, Env, and Tax (Figure 1). 
The production of these viral proteins induces an immune response toward HTLV-1 [6]. The first 
specific antibodies to appear are directed against Gag and are predominant in the first two months. 
Subsequently, anti-Env and anti-Tax antibodies appear. In addition, the majority of HTLV-1-specific 
CD8
+ T cells recognize the Tax protein.  
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Figure 1. Schematic representation of the Human T-cell Leukemia Virus type 1 (HTLV-1) 
proviral  genome.  In  addition  to  the  common  retroviral  genes  (in  yellow),  the  provirus 
contains genes encoding different regulatory proteins. Among them, the Tax protein (in 
red) interacts with CREB (in blue) to bind to the Tax-responsive elements (TxREs). Tax 
then  stabilizes  the  TxRE-bound  complex  and  recruits  p300/CBP  to  stimulate  the  viral 
transcription and the production of the different viral proteins such as Gag, Env, and Tax. 
 
 
All retroviral genes have been thought to be transcribed through a single promoter located in the  
5'  LTR  of  the  provirus.  However,  the  presence  of  a  conserved  open  reading  frame  (ORF)  in  the 
complementary strand of the HTLV-1 provirus suggested the existence of viral mRNA of negative 
polarity. The existence of antisense transcription in HTLV-1 was demonstrated for the first time in 
1989  through  Northern  blot  analysis  of  RNA  extracted  from  an  HTLV-1-infected  cell  line  [7]. 
However, it is only 13 years later that we provided the first evidence of a protein termed HTLV-1 
basic leucine zipper (bZIP) factor (HBZ) produced from an HTLV-1 antisense transcript [8]. This 
finding led to a number of studies aimed at examining the transcript itself. The initial positioning of 
the hbz gene showed that it was located between the env gene and the last exon of the tax transcript 
(Figure 2). RACE experiments have revealed that transcription initiation sites were all located in the 3' 
LTR, precisely in the R and U5 regions [9]. Importantly, these experiments showed that the antisense 
transcript was spliced and produced a major spliced form with the ATG initiation codon located in 
exon 1 in the 3' LTR segment. These results were also confirmed by other teams using different 
approaches  [10,11].  Focus  was  also  given  to  the  identification  of  the  3'  end  of  the  transcript.  In 
agreement with the initial suggested polyA signal, we and others have confirmed its usage for 3' 
processing of the HBZ transcript and addition of the polyA tail [9,11]. 
2. HBZ Is a c-Fos-Like Factor  
HBZ is nuclear factor containing a transcriptional activation domain at its N-terminus and a ZIP 
domain at its C-terminus [8,12,13]. Different isoforms have been described, sharing about 95% amino 
acid  sequence  identity  differing  only  at  their  N  termini  [9,10,14].  The  most  abundant  HBZ  form 
detected in HTLV-1-infected cell lines corresponds to the 206 amino acid-long isoform produced from 
the major spliced variant. This messenger can be detected in numerous infected cell lines and directly 
in cells isolated from infected patients [9–11,15–18]. HBZ interacts with c-Jun and JunB through its 
ZIP domain [19,20]. This interaction leads to a reduction in c-Jun and JunB DNA-binding activity and 
prevents these proteins from activating transcription of AP-1-dependent promoters by sequestering Viruses 2011, 3                         
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them  into  nuclear  bodies  [21,22],  corresponding  to  transcriptionally  inactive  sites.  It  has  also  been 
proposed that HBZ inhibits c-Jun activity by promoting its degradation through a proteasome-dependent 
pathway [20]. 
Figure 2. Regulation of sense and antisense transcription by HTLV-1 basic leucine zipper 
(bZIP) factor (HBZ). Antisense transcripts initiated from the 3' LTR are responsible for 
encoding the HBZ protein. HBZ then downmodulates Tax-dependent viral gene expression 
by interacting with CREB and p300/CBP. HBZ could also activate its own expression by 
forming HBZ/JunD heterodimers able to interact with the Sp1 transcription factor bound to 
the Sp1-binding sites involved in the stimulation of antisense transcription. HBZ would 
thus render the infected cells less likely to be targeted by the immune response through 
lower expression of viral proteins but should also promote T-lymphocyte proliferation by 
controlling cellular transcription through AP-1, NF-B and E2F-1 pathways.  
 
2.1. HBZ Down-Regulates the Viral Sense Transcription but Stimulates the Antisense Transcription 
Early studies demonstrated that the ZIP domain of HBZ was also able to interact with CREB-2 [8], 
a  member  of  the  ATF/CREB  family  that  is  involved  in  Tax-dependent  activation  of  the  viral 
transcription [23]. This interaction blocks the binding of CREB-2 to the HTLV-1 LTR and thereby 
abolishes  Tax-dependent  activation  of  promoter  activity  [8,24].  These  preliminary  data  were 
confirmed  through  standard  chromatin  immunoprecipitation  experiments,  which  highlighted  the 
displacement of CREB from the HTLV-1 LTR upon HBZ expression [25]. In addition, HBZ harbors 
an N-terminal activation domain that contains two LXXLL-like motifs. These motifs mediate direct 
binding of HBZ to the cellular coactivators p300/CBP [26], which specifically occurs through the KIX 
domain that is conserved between the coactivators. p300 and CBP play central roles in activation of 
HTLV-1, as well as cellular transcription by serving as scaffolds for other transcriptional regulators to 
associate with promoters and through their histone acetyltransferase activity. In the context of HTLV-1 Viruses 2011, 3                         
 
 
460 
transcription, HBZ effectively displaces p300/CBP from the viral promoter. This mechanism appears 
to be more potent than that of the ZIP domain in mediating repression of viral transcription (Figure 2).  
HBZ also interacts with JunD [27], the third member of the Jun family. HBZ does not inhibit JunD 
activity unlike c-Jun and JunB. Indeed, HBZ is able to cooperate with JunD to enhance transcription 
by interacting with the Sp1 transcription factor. In these conditions, activation of transcription by this 
protein complex is mediated through binding sites for Sp1 present in the promoter [28]. Interestingly, 
Sp1 sites have been described to be involved in the regulation of antisense transcription from the  
3' LTR [14,29]. Thus, HBZ could not only negatively control expression of the other viral proteins to 
avoid deleterious immune response but would also be able to stimulate its own expression.  
2.2. HBZ Controls Cellular Transcription 
Additional  HBZ  interaction  partners  of  HBZ  have  been  characterized.  By  conducting  a  yeast  
two-hybrid assay using HBZ, MafB was identified as a partner [30]. HBZ heterodimerizes with MafB 
via its ZIP domain. However, the role of this interaction remains unclear. It has been proposed that 
HBZ has a suppressive effect on Maf function [30], but when MafB was tested in the presence of HBZ 
in a gel-shift assay using a Maf recognition elements, the HBZ/MafB heterodimer directly bound DNA 
[31]. DNA binding was specific and is dependent both on the HBZ basic region and on DNA that 
flanked the central binding site. Because the sequence of the HBZ basic region is unique, it may have a 
distinct DNA-binding specificity and it remains possible that cellular promoters could be recognized  
in vivo by HBZ in association with Maf proteins.  
HBZ also stimulates JunD transcriptional activity [27]. By interacting with JunD, HBZ forms a 
complex with stronger accessibility to transcriptional factors or cofactors bound to cellular promoters 
[13]. Hence, the HBZ-JunD heterodimer is then able to cooperate with the Sp1 transcriptional factor to 
enhance  hTERT  transcription  through  Sp1-binding  sites  present  in  the  proximal  sequences  of  the 
promoter [28]. In addition to its ZIP domain, the activation domain of HBZ appears to be essential for 
up-regulating  the  hTERT  promoter  activity.  Recently,  expression  of  a  protein  involved  in  bone 
resorption, Dkk1, has also been demonstrated to be activated by HBZ through its interaction with 
p300/CBP [32]. However, this effect of HBZ is limited in HTLV-1-infected T-cell lines, which in part 
may be due to suppression of Dkk1 expression by Tax. Consequently, the ability of HBZ to regulate 
expression of Dkk1 and possibly other cellular genes may only be significant following loss of Tax 
expression, which is an event frequently observed during progression of ATL [33]. 
HBZ  has  also  been  found  to  bind  the  NF-B  subunit  p65  [34].  This  interaction  results  in  an 
inhibition of the classical NF-B activation pathway. Both activation and ZIP domains are involved in 
the binding of HBZ to p65. By interacting with p65, HBZ inhibits DNA binding of p65 like for c-Jun 
and JunB. However, HBZ is also able to increase expression of the E3 ubiquitin ligase, PDLIM2, 
resulting in ubiquitination and degradation of p65 [34]. PDLIM2 has also been described to suppress 
Tax-mediated tumorigenesis by recruiting Tax from its functional sites into the nuclear matrix where 
Tax is degraded by the proteasome [35]. Recently, immunoprecipitation experiments showed that HBZ 
also interacted with both Foxp3 and NFAT, interrupting the function of both cellular factors [36].  Viruses 2011, 3                         
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3. HBZ Promotes T-Lymphocyte Proliferation  
In addition to its capacity to disrupt AP-1 and NF-B pathways, observations favored a possible 
impact of HBZ on ATL development, specifically on ATL maintenance. In ATL cells, the occurrence 
of  5'  LTR  methylation  or  its  deletion  is  frequent,  thereby  leading  to  the  inhibition  of  viral  gene 
expression including Tax. In addition, as opposed to the 5' LTR, the 3' LTR is hypomethylated [37]. 
Moreover,  as  mentioned  above,  HBZ  could  stimulate  its  own  expression.  Taken  together,  these 
observations  explain why HBZ expression  is  consistently detected  in  ATL cells  [11]. It could be 
speculated that Tax might rather be involved in the first step of transformation while HBZ would act as 
a maintenance factor in ATL cells. Indeed, shRNA repression of hbz gene expression in established 
HTLV-1-transformed  cell  lines  and  newly  immortalized  T  lymphocytes  significantly  suppressed  
T-lymphocyte  proliferation  [38].  Very  recent  results  demonstrate  that  hbz  gene  induced  T-cell 
lymphoma in transgenic mice [36] but the long latent period before the onset of lymphoma in these 
mice confirms that additional events are necessary in addition of hbz expression. Moreover, the HBZ 
RNA  itself  could  also  promote  T-cell  proliferation  [11].  This  model  would  therefore  argue  for  a 
possible bimodal function of HBZ whereby the protein could act upon different cell function/viral gene 
expression  while  the  transcript  would  positively  enhance  cell  proliferation.  Microarray  analysis 
indicated that the HBZ RNA was responsible for the upregulation of E2F-1 [11].  
4. Regulation of the Balance between Sense and Antisense Transcription 
CD4
+ T cells freshly isolated from HAM/TSP patients spontaneously expressed HTLV-1 sense 
transcripts from the 5' LTR, initially Tax transcript then Gag RNA (Figure 3). This expression reached 
a peak after about 24 h of incubation. With respect to antisense transcription from the 3' LTR, HBZ 
RNA expression increased after two days of culture and then plateaued to stable levels [39]. It is 
interesting to notice that increase of antisense transcription from the 3' LTR corresponds to a decrease 
of sense expression from 5' LTR suggesting that the loss of sense transcription results in increased 
antisense  transcription.  We  have  already  observed  such  results  by  analyzing  sense/antisense 
transcription from 293T cells transfected with either a full-length proviral clone or a molecular clone 
without its 5' LTR [9,40]. The absence of the 5' LTR stimulated the synthesis of antisense transcripts 
from the 3' LTR. It might be postulated that sense and antisense transcription could compete for a 
limited amount of common cellular transcription factors involved in the formation of the preinitiation 
complex on both LTRs. Indeed, it has been demonstrated that the two HTLV-1 LTRs are functionally 
equivalent  in  HTLV-1-infected  cell  lines  and  ATL  cells  with  a  nearly  equal  distribution  of 
transcription  factors  (CREB,  ATF-1,  c-Fos,  c-Jun)  and  regulatory  cofactors  (p300/CBP,  RNA 
polymerase  II)  [41].  Thus  sense/antisense  transcription  is  initiated  by  the  same  cellular  and  viral 
activators including CREB and Tax  [29]. It is thus likely that sense transcription especially upon 
induction by the viral trans-activator Tax contributes in keeping antisense transcription to low levels. 
On  the  other  hand,  when  Tax  expression  is  disrupted  by  different  mechanisms  including  down-
regulation of its expression by accessory viral proteins (like Rex and p30) or by hypermethylation of 
the 5' LTR, antisense transcription is thereby augmented. Data collected from different infected cells 
have also provided important information as to the process of HTLV-1 gene expression. By real-time 
RT-PCR, quantification of HBZ and Tax mRNA levels confirmed that primary ATL cells expressed Viruses 2011, 3                         
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high  levels  of  HBZ  but  low  levels  of  Tax  mRNA.  This  pattern  was  distinguishable  from  that  of 
infected T- cell lines, showing low HBZ and high Tax mRNA levels [17]. However, Tax has also been 
shown to induce cellular senescence [42]. The decline of Tax expression may be a result of the loss of 
cells that express high levels of Tax. Only cells that express low levels of Tax and high levels of HBZ 
could undergo mitotic expansion.  
Figure  3.  Kinetic  analysis  of  HTLV-1  transcription.  Quantification  of  tax  (red),  gag 
(yellow)  and  hbz  (green)  mRNAs  in  lymphocytes  from  HTLV-1  associated 
myelopathy/tropical spastic paraparesis (HAM/TSP) patients following ex vivo culture. 
 
 
Recent  data  using  the  in  vivo  rabbit  model  have  further  reinforced  the  notion  that  antisense 
transcription is maintained over time unlike sense transcription. Kinetic analysis revealed that sense 
transcription was expressed at the highest levels immediately after infection and then progressively 
declined over time [43]. Conversely, antisense transcription was expressed at a low level early after 
infection  and  continued  to  increase  before  reaching  a  plateau.  These  results  confirm  an  inverse 
correlation between sense/antisense transcription and Tax/HBZ expression over time, which provided 
important evidence linking HBZ expression to the survival of the infected cells in the host. Moreover, 
very recent results show that an efficient HBZ-specific CD8
+ T-cell response reduced the proviral load 
and  the  risk  of  HAM/TSP  [44],  confirming  that  the  anti-HBZ  response  constitutes  an  efficient 
protection  against  the  proliferation  of  HTLV-1-infected  cells.  On  the  other  hand,  the  same  
HBZ-specific cytotoxic T-lymphocyte clone was unable to lyse leukemic cells isolated from a patient 
with ATL [45]. Further clarification of the mechanism involved in the resistance of ATL cells to the 
HBZ-specific T-cell response is needed to understand this observation. 
5. Antisense Transcription and Other HTLVs 
Unlike  HTLV-1,  the  human  HTLV-2  has  been  linked  to  HAM-like  pathologies,  but  not  to 
leukemia. As HBZ has been associated with ATL maintenance, our group has searched for a possible 
equivalent  antisense  transcript  in  HTLV-2.  We  have  indeed  reported  that  HTLV-2  produced  an 
antisense spliced transcript, which initiated in the 3' LTR and encoded for a protein that we have Viruses 2011, 3                         
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termed Antisense Protein of HTLV-2 (APH-2) (Figure 4) [46]. Distinctively from HBZ, APH-2 does 
not  possess  a  bZIP  consensus  domain  but  retained  the  capacity  to  inhibit  Tax2-dependent  LTR 
activation and to interact with the CREB transcription factor. Furthermore, unlike HBZ, APH-2 did not 
co-localize with the nucleolus, although in non-T and T cells, it did demonstrate a nuclear localization. 
These results have indicated that HTLV-1 is not a unique retrovirus in its capacity to produce encoding 
antisense transcripts. They also raised the intriguing possibility that differences in protein domains and 
in nuclear distribution suggest potential dissimilarities in their capacity to modulate cellular and/or 
viral expression. These functional differences could eventually provide an explanation for the inability 
of HTLV-2 to cause leukemia in infected patients. Further studies will be required to determine how 
HBZ and APH-2 vary in their impact on cellular gene expression. 
Figure 4. Schematic representation of antisense open reading frame (ORF) in other HTLV 
proviral  genomes.  Positioning  of  antisense  transcript-encoded  proteins  termed  APH  in 
HTLV-2, HTLV-3 and HTLV-4 is similar to HBZ in HTLV-1. These proteins do share 
certain additional similarities with HBZ although their cellular localization and amino acid 
sequence do indicate functional differences. Recent results from our team have confirmed 
that both synthesis of APH-3 and APH-4 are dependent on a spliced transcript. 
 
 
We  have  also  recently  tested  whether  the  newly  discovered  human  retroviruses  HTLV-3  and  
HTLV-4 [47,48] were equally capable of producing an antisense transcript. Indeed, our results have 
indicated that both viruses produce a spliced and polyadenylated antisense transcript. The encoded 
proteins  showed  distinct  localization;  the  HTLV-3  antisense  protein  being  both  nuclear  and 
cytoplasmic,  while  the  HTLV-4  counterpart  being  almost  exclusively  contained  in  the  nucleus 
(Larocque et al., unpublished results). In addition, alike APH-2, both APH-3 and APH-4 lacked a Viruses 2011, 3                         
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consensus bZIP domain but did block LTR activation mediated by their respective Tax protein. Thus, 
cellular localization is distinguishing these various antisense transcript-encoded retroviral proteins and 
could suggest that they functional affect infected cells in a different manner. We are currently looking 
at how these proteins alter activation of transcription factors known to be functionally modulated by 
HBZ. Functional comparison of these viral proteins should provide important information as to their 
role in viral replication and alteration at the cellular level. 
6. Summary and Conclusion 
Since  the  discovery  of  HBZ  in  2002,  accumulating  evidence  suggests  that  the  development  of 
HTLV-1 infection requires the Tax and HBZ genes, whose expression is respectively controlled by the 
5' and 3' LTR. In the first stage of the infection of T cells by HTLV-1, Tax expression is high and 
through a positive feedback stimulates protein viral synthesis, virus production, and viral infection. 
However, cells highly expressing HTLV-1 proteins are eliminated by the humoral response and CTL 
activity  of  the  host.  At  this  stage,  HBZ  can  play  a  crucial  role  by  down-regulating  the  
5'-LTR-dependent viral transcription and may allow infected cells to evade the immune response. In 
additionally, HBZ promotes the proliferation of infected T lymphocytes. This dual action probably 
confers a survival advantage on HBZ-expressing cells and is consistent with the observation that HBZ 
favors the establishment of persistent infection in HTLV-1-inoculated rabbits [24] and induces T-cell 
lymphoma and systemic inflammation [36]. Henceforth, it is clear that interfering with HBZ function 
may be a useful strategy for the treatment of ATL and HAM/TSP [49]. Future studies will also permit 
to determine whether APH-2 also plays an essential role in the development of HTLV-2-associated 
diseases. 
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